ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
EXTENDED-RELEASE FORMULATIONS OF HUMAN CHORIONIC GONADOTROPIN (HCG)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 213709" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.innocorepharma.com/nl/Technologies/API[/URL]</p><p></p><p><strong>API</strong></p><p><em>SynBiosys is a sustained release technology using several monomers to form a biodegradable polymer matrix in which APIs can be entrapped. When brought in an aqueous environment, the polymers swell and gradually release the APIs by diffusion. Release time can be regulated from days up to several months.</em></p><p><em></em></p><p><em><strong>*Protein & Antibodies</strong></em></p><p><strong><em>*Peptides</em></strong></p><p><em><strong>*SmallMolecules</strong></em></p><p></p><p></p><p><strong>Polymer technologies</strong></p><p><em>InnoCore has two patented sustained release technologies that serve as a platform for obtaining advanced long-acting injectable (LAI) formulations of pharmaceutical ingredients. The SynBiosys® and InGell® polymers are biodegradable and bioresorbable in which APIs can be entrapped. The long-acting release mechanism of drugs with SynBiosys® microspheres is based upon diffusion whereas the InGell® gels erode completely via surface erosion. Optionally, PLGA could be used as a drug carrier in microspheres although with limited patent protection.</em></p><p><em></em></p><p><em><strong>*Synbiosys</strong></em></p><p><em><strong>*Ingell</strong></em></p><p><strong><em>*PLGA</em></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Drug carriers</strong></p><p><em>InnoCore’s technologies can be applied in several administration forms. Our SynBiosys® platform is compatible with state-of-the-art depot formulation technologies, like microspheres, microrods, microparticles, nanoparticles, and in-situ forming implants or gels. The technology is also suitable for implants, fleece’s, and for spray coating of implants, like coronary stents and other vascular devices. The InGell® technology is an advanced injectable gel drug depot system, offering unparalleled retention and release of active pharmaceutical ingredients from a soft, localized drug depot. The InGell technology is available as a water-borne gel (hydrogel consisting of 75-90% of buffer) and a water-free gel (100% pure polymer, LQP).</em></p><p><em></em></p><p><em><strong>*Microspheres</strong></em></p><p><em><strong>*Gell</strong></em></p><p><em><strong>*Implant</strong></em></p><p><em><strong>*Nanospheres</strong></em></p><p><em><strong>*Coating</strong></em></p><p><strong><em>*Other</em></strong></p><p><em></em></p><p><em></em></p><p><strong>Sustained release</strong></p><p><em>In today's health care industry, sustained drug delivery has become key in pharmaceutical product development. Innovative sustained release technologies allow for increased performance of new and existing pharmaceutical compounds. Patients benefit from the enhanced efficacy of pharmaceutical products and from the reduction of side effects.</em></p><p><em></em></p><p><em></em></p></blockquote><p></p>
[QUOTE="madman, post: 213709, member: 13851"] [URL unfurl="true"]https://www.innocorepharma.com/nl/Technologies/API[/URL] [B]API[/B] [I]SynBiosys is a sustained release technology using several monomers to form a biodegradable polymer matrix in which APIs can be entrapped. When brought in an aqueous environment, the polymers swell and gradually release the APIs by diffusion. Release time can be regulated from days up to several months. [B]*Protein & Antibodies[/B][/I] [B][I]*Peptides[/I][/B] [I][B]*SmallMolecules[/B][/I] [B]Polymer technologies[/B] [I]InnoCore has two patented sustained release technologies that serve as a platform for obtaining advanced long-acting injectable (LAI) formulations of pharmaceutical ingredients. The SynBiosys® and InGell® polymers are biodegradable and bioresorbable in which APIs can be entrapped. The long-acting release mechanism of drugs with SynBiosys® microspheres is based upon diffusion whereas the InGell® gels erode completely via surface erosion. Optionally, PLGA could be used as a drug carrier in microspheres although with limited patent protection. [B]*Synbiosys *Ingell[/B][/I] [B][I]*PLGA[/I] Drug carriers[/B] [I]InnoCore’s technologies can be applied in several administration forms. Our SynBiosys® platform is compatible with state-of-the-art depot formulation technologies, like microspheres, microrods, microparticles, nanoparticles, and in-situ forming implants or gels. The technology is also suitable for implants, fleece’s, and for spray coating of implants, like coronary stents and other vascular devices. The InGell® technology is an advanced injectable gel drug depot system, offering unparalleled retention and release of active pharmaceutical ingredients from a soft, localized drug depot. The InGell technology is available as a water-borne gel (hydrogel consisting of 75-90% of buffer) and a water-free gel (100% pure polymer, LQP). [B]*Microspheres *Gell *Implant *Nanospheres *Coating[/B][/I] [B][I]*Other[/I][/B] [I] [/I] [B]Sustained release[/B] [I]In today's health care industry, sustained drug delivery has become key in pharmaceutical product development. Innovative sustained release technologies allow for increased performance of new and existing pharmaceutical compounds. Patients benefit from the enhanced efficacy of pharmaceutical products and from the reduction of side effects. [/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
EXTENDED-RELEASE FORMULATIONS OF HUMAN CHORIONIC GONADOTROPIN (HCG)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top